An update on the potential mechanism of gallic acid as an antibacterial and anticancer agent.
antibacterial
anticancer
gallic acid
health benefits
polyphenol
Journal
Food science & nutrition
ISSN: 2048-7177
Titre abrégé: Food Sci Nutr
Pays: United States
ID NLM: 101605473
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
20
04
2023
revised:
15
07
2023
accepted:
25
07
2023
medline:
12
10
2023
pubmed:
12
10
2023
entrez:
12
10
2023
Statut:
epublish
Résumé
Drug resistance to antibacterial and anticancer drugs is one of the most important global problems in the treatment field that is constantly expanding and hinders the recovery and survival of patients. Therefore, it is necessary to identify compounds that have antibacterial and anticancer properties or increase the effectiveness of existing drugs. One of these approaches is using natural compounds that have few side effects and are effective. Gallic acid (GA) has been identified as one of the most important plant polyphenols that health-promoting effects in various aspects such as bacterial and viral infections, cancer, inflammatory, neuropsychological, gastrointestinal, and metabolic disease. Various studies have shown that GA inhibits bacterial growth by altering membrane structure, and bacterial metabolism, and inhibits biofilm formation. Also, GA inhibits cancer cell growth by targeting different signaling pathways in apoptosis, increasing reactive oxygen species (ROS) production, targeting the cell cycle, and inhibiting oncogenes and matrix metalloproteinases (MMPs) expression. Due to the powerful function of GA against bacteria and cancer cells. In this review, we describe the latest findings in the field of the sources and chemical properties of GA, its pharmacological properties and bioavailability, the antibacterial and anticancer activities of GA, and its derivatives alone, in combination with other drugs and in the form of nanoformulation. This review can be a comprehensive perspective for scientists to use medicinal compounds containing GA in future research and expand its clinical applications.
Identifiants
pubmed: 37823155
doi: 10.1002/fsn3.3615
pii: FSN33615
pmc: PMC10563697
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
5856-5872Informations de copyright
© 2023 The Authors. Food Science & Nutrition published by Wiley Periodicals LLC.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Molecules. 2011 Jul 25;16(8):6255-70
pubmed: 21788933
Front Immunol. 2020 Sep 16;11:580208
pubmed: 33042163
Bioorg Med Chem. 2004 Jul 1;12(13):3581-9
pubmed: 15186842
Bioorg Med Chem. 2008 Apr 1;16(7):3791-9
pubmed: 18295493
Food Chem Toxicol. 2010 May;48(5):1334-40
pubmed: 20197077
Evid Based Complement Alternat Med. 2011;2011:431021
pubmed: 21647315
Anticancer Res. 2011 Sep;31(9):2821-32
pubmed: 21868525
ACS Appl Bio Mater. 2019 May 20;2(5):2092-2101
pubmed: 35030648
Cancer Lett. 2007 Jan 8;245(1-2):156-62
pubmed: 16488533
J Agric Food Chem. 2004 May 5;52(9):2527-32
pubmed: 15113151
Anticancer Res. 2012 May;32(5):1595-602
pubmed: 22593437
Invest New Drugs. 2010 Jun;28(3):251-9
pubmed: 19300909
Oncol Rep. 2000 Nov-Dec;7(6):1221-3
pubmed: 11032918
FEMS Yeast Res. 2010 May;10(3):244-51
pubmed: 20132313
BMC Complement Altern Med. 2017 Feb 8;17(1):102
pubmed: 28178952
J Pharm Biomed Anal. 2018 Sep 10;159:490-512
pubmed: 30048897
Antibiotics (Basel). 2021 Dec 07;10(12):
pubmed: 34943714
Cancer Lett. 2015 Jun 28;362(1):8-14
pubmed: 25796441
Antimicrob Resist Infect Control. 2019 Jul 16;8:118
pubmed: 31346459
Mini Rev Med Chem. 2018;18(15):1283-1293
pubmed: 29600764
Chin Med. 2021 Aug 6;16(1):72
pubmed: 34362401
Biomed Pharmacother. 2021 Jan;133:110985
pubmed: 33212373
Mini Rev Med Chem. 2021;21(17):2544-2550
pubmed: 33402087
Molecules. 2015 Aug 28;20(9):15666-85
pubmed: 26343624
Arch Pharm (Weinheim). 2011 Nov;344(11):703-9
pubmed: 21953995
Oncol Lett. 2013 Dec;6(6):1749-1755
pubmed: 24843386
Nanomaterials (Basel). 2018 Feb 02;8(2):
pubmed: 29393902
Int J Biol Macromol. 2021 Jan 15;167:10-22
pubmed: 33249153
Phytother Res. 2019 Apr;33(4):1208-1221
pubmed: 30838722
Mol Inform. 2023 Jan;42(1):e2200016
pubmed: 36065495
FEMS Microbiol Lett. 2013 Apr;341(1):62-7
pubmed: 23350629
Oncol Rep. 2019 Mar;41(3):1779-1788
pubmed: 30747218
Pharmaceutics. 2021 May 21;13(6):
pubmed: 34063874
Cancer Cell Int. 2020 Jan 13;20:18
pubmed: 31956296
Braz J Microbiol. 2012 Jul;43(3):938-45
pubmed: 24031910
Am J Clin Nutr. 2005 Jan;81(1 Suppl):230S-242S
pubmed: 15640486
Oncol Rep. 2021 Oct;46(4):
pubmed: 34476509
Crit Rev Food Sci Nutr. 2020;60(12):2083-2097
pubmed: 31257900
Microb Cell Fact. 2015 Dec 30;14:209
pubmed: 26715179
Microb Drug Resist. 2013 Aug;19(4):256-65
pubmed: 23480526
J Colloid Interface Sci. 2019 May 1;543:114-121
pubmed: 30782517
Regul Toxicol Pharmacol. 2019 Feb;101:71-78
pubmed: 30465803
Vet Res. 2018 Oct 4;49(1):101
pubmed: 30286813
Nanomaterials (Basel). 2017 Nov 02;7(11):
pubmed: 29099064
Biomol Ther (Seoul). 2022 Mar 1;30(2):151-161
pubmed: 34261818
Nanoscale Res Lett. 2016 Dec;11(1):491
pubmed: 27822913
Biomed Res Int. 2014;2014:814590
pubmed: 24804249
Biomedicines. 2020 Oct 11;8(10):
pubmed: 33050619
J Biomol Struct Dyn. 2021 Nov;39(18):6853-6869
pubmed: 32752940
Phytother Res. 2020 Oct;34(10):2534-2556
pubmed: 32307747
Front Public Health. 2020 Nov 12;8:612844
pubmed: 33282821
Int J Nanomedicine. 2018 Dec 11;13:8487-8506
pubmed: 30587973
IUBMB Life. 2021 Feb;73(2):398-407
pubmed: 33372372
Int J Nanomedicine. 2022 Nov 30;17:5781-5807
pubmed: 36474524
Front Pharmacol. 2019 Jan 04;9:1486
pubmed: 30662404
Nat Prod Rep. 2009 Aug;26(8):1001-43
pubmed: 19636448
Avicenna J Phytomed. 2019 Nov-Dec;9(6):574-586
pubmed: 31763216
Crit Rev Anal Chem. 2016 May 3;46(3):257-65
pubmed: 26440222
J Microbiol Immunol Infect. 2022 Dec;55(6 Pt 2):1255-1262
pubmed: 34326026
Cancer Lett. 2009 Dec 28;286(2):161-71
pubmed: 19589639
Antibiotics (Basel). 2021 Dec 30;11(1):
pubmed: 35052923
Anticancer Res. 2018 Apr;38(4):2057-2067
pubmed: 29599323
J Dairy Sci. 2013 Aug;96(8):4912-20
pubmed: 23769374
Melanoma Res. 2011 Aug;21(4):267-73
pubmed: 21734530
Mol Biomed. 2021 Sep 10;2(1):27
pubmed: 35006446
Nat Rev Cancer. 2013 Oct;13(10):714-26
pubmed: 24060863
BMC Microbiol. 2020 May 14;20(1):118
pubmed: 32410630
J Drug Target. 2021 Nov;29(9):941-959
pubmed: 33703979
Int J Nanomedicine. 2016 Jul 27;11:3347-56
pubmed: 27555764
Semin Cancer Biol. 2017 Oct;46:119-131
pubmed: 28830771
Pathog Glob Health. 2015;109(7):309-18
pubmed: 26343252
Int J Oncol. 2009 Sep;35(3):547-57
pubmed: 19639175
Oncol Rep. 2011 Jul;26(1):177-84
pubmed: 21503582
Front Microbiol. 2019 Apr 18;10:829
pubmed: 31057527
Toxicol In Vitro. 2012 Apr;26(3):396-405
pubmed: 22245431
Food Chem. 2019 Sep 30;293:315-322
pubmed: 31151617
Int J Antimicrob Agents. 2013 Dec;42(6):519-23
pubmed: 24016798
Can J Microbiol. 2014 Oct;60(10):629-38
pubmed: 25216286
Bioimpacts. 2018;8(3):185-194
pubmed: 30211078
AAPS PharmSciTech. 2013 Sep;14(3):1025-33
pubmed: 23800857
Drug Des Devel Ther. 2020 Apr 23;14:1583-1592
pubmed: 32425504
World J Gastroenterol. 2016 Apr 21;22(15):3952-61
pubmed: 27099438
Mol Nutr Food Res. 2011 Dec;55(12):1798-808
pubmed: 22038937
Oncol Rep. 2016 May;35(5):3075-83
pubmed: 26987028
Mol Nutr Food Res. 2016 Mar;60(3):542-50
pubmed: 26640139
Microb Pathog. 2016 Oct;99:56-61
pubmed: 27497894
Pharm Pat Anal. 2015;4(4):305-15
pubmed: 26174568
Cancers (Basel). 2021 Dec 10;13(24):
pubmed: 34944840
Food Chem. 2021 Jun 1;346:128949
pubmed: 33418419
J Ethnopharmacol. 2021 Jun 28;274:114059
pubmed: 33794333
Sci Rep. 2017 Aug 16;7(1):8325
pubmed: 28814799
J Agric Food Chem. 2011 Jan 26;59(2):763-71
pubmed: 21166414
Ecotoxicol Environ Saf. 2020 Dec 1;205:111342
pubmed: 32971455
Pathogens. 2020 Oct 03;9(10):
pubmed: 33023003
J Biochem Mol Toxicol. 2021 Feb;35(2):e22638
pubmed: 33002289
Molecules. 2020 Oct 10;25(20):
pubmed: 33050462
J Appl Microbiol. 2022 Feb;132(2):949-963
pubmed: 34365707
J Colloid Interface Sci. 2014 Oct 1;431:194-9
pubmed: 25000181
Appl Microbiol Biotechnol. 2018 Feb;102(4):1837-1846
pubmed: 29327068
Drug Dev Ind Pharm. 2021 Oct;47(10):1656-1663
pubmed: 35179095
Front Pharmacol. 2020 Aug 20;11:1222
pubmed: 32973496
Cancer Cell Int. 2019 Jun 03;19:154
pubmed: 31171918